Despite the widespread prevalence of drug-MATERIALS AND METHODS
resistant Plasmodium falciparum, chloroquine remains an important drug in the treatment of Malaria-naive Panamanian owl monkeys malaria in many parts of the world.' The dis-(Aotus lemurinus lemurinus) were used as hosts covery that chloroquine resistance could be re-for chloroquine-resistant P. falciparum, and preversed in vitro by using verapamil suggested a viously described procedures and husbandry novel approach to combination therapy and practices were followed." The chloroquine-reraised hopes that the clinical response to chlo-sistant Vietnam Smith strain was used in the roquine could be restored.? Numerous com-initial experiments with chloroquine combined pounds besides verapamil have now been shown with verapamil or SKF 2133-A (a chlorpromato reverse chloroquine resistance in vitro, 3 -6 but zine analog). In subsequent studies, a recrudesexperience with resistance modulators plus chlo-cent isolate from a Vietnam Smith strain-inroquine in vivo is limited. In various mouse mafected Aotus monkey treated with chloroquine laria models, verapamil, cyproheptadine, keto-was used. This strain, designated Vietnam Smitlh/ tifen, and amlodipine have been shown to reverse RE, was more resistant to chloroquine as evi-S.
chloroquine resistance,'-` but primate in vivo denced by limited effects on parasitemia in Aotus Sdata versus chloroquine-resistant P. falciparum monkeys receiving 20 mg/kg/day of chloroquine are limited to a single observation."' In that study, for seven days. desipramine given in combination with chloroEach monkey was inoculated intravenously Squine cleared parasitemia in Aotus monkeys in-with 5 x 106 trophozoites of the chloroquinefected with chloroquine-resistant P. falciparum, resistant Vietnam Smith or Vietnam Smith/RE but in each case the infection eventually recrustrain of P. falciparum. The inoculum size prodesced. In this study, we report our results with duced a parasitemia of at least 5 x IO1/mm' by a series of resistance modulators in a Panaman-the fifth day postinoculation, at which time treat-"ian Aolus-P. falciparum model. The results con-ment was begun. Stock solutions of water-soluble firm the reversal of P. falciparum chloroquine drug were prepared at appropriate concentraresistance in Aotus and allow for comparison of tions and maintained at 4*C during the course relative abilities of different compounds to re-of treatment. A suspension of water-insoluble verse chloroquine resistance, drugs was prepared in 0.3% methylcellulose just
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126 Iim~limEIl prior to use. All drugs were administered by gas-attributed to a drug affect. An infection was contric intubation in a volume of 7.0 ml, followed sidered cured if the parasitemia cleared and blood by a 7.0-ml rinse with either water or 0.3% meth-films remained negative for 100 days after the ylcellulose. Chloroquine alone or in combination end of treatment. Infections that failed to be cured with the candidate resistance modulator drug was by the initial treatment were subsequently treatgiven orally for either three or seven consecutive ed with higher doses ofresistance modulator plus days. In several experiments, the putative resis-chloroquine or with mefloquine. Re-treatment tance modulator was given three times per day data were not considered in the analysis of drug (8:00 AM, noon, and 4:00 PM) for three or seven efficacy because of the high rate of self-limiting days. A 20 mg/kg dose ofchloroquine, given once infections (7 3%) observed in this model. " I Clear "a day for either three or seven days, was used as evidence of drug efficacy can be observed through "a negative control in all experiments. Adminis-the peak phase of parasitemia, which is up to 8-tration of chloroquine in either three daily doses 11 days from initiation of patency. Parasitemia j of 20 mg/kg or seven daily doses of 5-20 mg/ in self-limiting infections begins to decrease 8-kg is effective at curing infections with chloro-14 days after initiation of patency." quine-susceptible parasites in Aotus; however, these regimens are not effective against the Vi-RESULTS etnam Smith or Vietnam Smith/RE strains. 12 Giemsa-stained blood smears were prepared Experiments designed to detect the ability of from all animals and examined daily beginning verapamil to reverse chloroquine resistance in the day after inoculation until parasitemia was Aotus involved using two different treatment regcleared and for at least seven days thereafter. At imens. In the first experiments, verapamil was that time, blood films were examined twice a administered at a dose of 25 or 50 mg/kg once week up to 100 days after treatment. Thick blood a day for three days with or without chloroquine films were considered negative if no parasites (Figure 1 ). In Aotus monkeys inlected with the were seen after examination for at least five min.
Vietnl .n Smith strain, parasitemia in two aniTen or less parasites on a thick blood film were mals receiving 20 mg/kg ofchloroquine was not recorded as < 10. Parasitemia was enumerated significantly affected and one died from malaria by the Earle-Perez technique' 3 and expressed as ( Figure I A). Parasitemia remained high for more number of parasites/mm 3 . Treated animals were than seven days subsequent to treatment with 25 observed twice a day for signs of drug toxicity, mg/kg of verapamil alone (Figure 1 B) . Parasitas evidenced by abnormal behavior, anorexia, emia in each monkey became negative by day diarrhea, or vomiting. Necropsies were per-21 post-treatment; however, the rate of parasite formed on all animals that died. In conducting clearance was equal to that in self-limiting Vithe research described in this report, the inves-etnam Smith infections and could not be attribtigators adhered to the Guide for the Care and uted to a drug effect. A three-day dosage of 50 Use of Laboratory Animals, as promulgated by mg/kg of verapamil alone had no effect upon the National Research Council.
parasitemia and both monkeys died of apparent The classification of treatment outcomes was drug toxicity 4-6 days after the completion of adapted from Schmidt,' 4 and the outcome of each treatment. Two animals received 25 mg/kg of infection was compared with untreated controls verapamil plus 20 mg/kg of chloroquine (Figure and monkeys treated with chloroquine or the I C). Parasitemia became negative in both monresistance modulator alone. The infection was keys by day 21 post-treatment, but again at a rate considered suppressed when parasitemia per-similar to that seen in untreated infections. Two sisted throughout treatment, but was reduced to monkeys received 50 mg/kg of verapamil plus less than one-fiftieth the level of parasitemia in chloroquine and both died, one of apparent drug the control on the same day postinitiation of toxicity and the other of malaria. treatment. An infection was considered cleared
In the second series of experiments with verif the parasitemia became negative by 12 days apamil and chloroquine, the Vietnam Smith/RE after the infection became patent and remained strain was used and divided doses of verapamil negative for seven days; clearance ofparasitemia were given to reduce the toxicity observed with after the infection was patent for 12 days was higher daily doses in the first experiment. Verindicative ofa self-limiti-.g infection and was not apamil (5 mg/kg) was given three times per day (8:00 AM, noon, and 4:00 PM) and chloroquine ( Figure 4E ). The 20 mg/kg dose of chlorprom-(20 mg/kg) was given once a day (8:00 AM) for azine plus chloroquine cleared parasitemia in four three days (Figure 2) . Parasitemia was not sig-of four treated monkeys, and cured the infections nificantly affected in two monkeys given 5 mg/ in three of these ( Figure 417 ). The results were kg ofverapamil (15 mg/kg/day) plus chloroquine similar when prochlorperazine plus chloroquine or in two monkeys given chloroquine alone. No was used in the same seven-day treatment regiresponse in parasitemia was seen in monkeys men ( Figure 4B and C). Two of two monkeys administered the same doses ofverapamil alone, were cleared of parasitemia after receiving 10 An analog of tiapamil (Ro 11-2933) that was mg/kg of prochlorperazine and 20 mg/kg ofchlopreviously shown to reverse chloroquine resis-roquine ( Figure 4B ). Parasitemia in both montance in vitro 3 was tested in a modified seven-keys recrudesced by day 18 post-treatment. The day regimen. This analog (20 mg/kg) was given higher dose of prochlorperazine (20 mg/kg) plus three times per day for seven days and chloro-chloroquine cleared and cured infections of the quine (20 mg/kg) was administered once a day chloroquine-resistant Smith/RE strain in two for three days ( Figure 3A) . Parasitemia was sup-monkeys ( Figure 4C ). No response in parasitpressed in both monkeys receiving the combi-emia was observed when chlorpromazine, nation treatment, but it began to increase by the prochlorperazine, or chloroquine were adminseventh day of treatment.
istered alone (Figure 4B 
-D). A chlorpromazine analog (SKF 2133-A) that
The antihistaminic agents cyproheptadine and reverses chloroquine and quinine resistance in ketotifen were evaluated in combination with vitro 3 was tested in combination with chloro-chloroquine in a seven-day treatment regimen. quine in Aotus monkeys ( Figure 3B ). Parasitemia No significant reduction in parasitemia was seen was not affected by treatment with either 5 or 10 when either cyproheptadine, ketotifen, or chlomg/kg of SKF 2133-A plus 20 mg/kg of chlo-roquine were given alone ( Figure 5B and D) . In roquine given once a day for three days.
addition, no response was noted when cyproTwo additional phenothiazines, chlorproma-heptadine (10 or 20 mg/kg) plus chloroquine (20 zine and prochlorperazine, were evaluated in mg/kg) were given in combination once a day combination with chloroquine over a seven-day for seven days ( Figure 5C ). One monkey died of treatment regimen (Figure 4) . The low dose of apparent cardiac toxicity on day 3 of treatment chlorpromazine (10 mg/kg) plus chloroquine (20 when given 20 mg/kg of cyproheptadine plus mg/kg) cleared the parasitemia in four of four chloroquine. A slight decrease in parasitemia in monkeys and cured the infection in one animal one of two monkeys was seen with 10 mg/kg of L1•..... ketotifen plus chloroquine, whereas suppression cence on days 10-21 post-treatment, was obwas observed in one of two animals receiving 20 served in six other monkeys. This represents the mg/kg of ketotifen plus chloroquine. No monfirst report of cures in an in vivo study using keys were cleared of parasitemia or cured of inresistance modulators plus chloroquine against fection after receiving any combination of either chloroquine-resistant P. falciparum. cyproheptadine or ketotifen plus chloroquine.
Although treatment regimens varied, the pronounced differences in treatment outcomes allow
DISCUSSION
for comparison of the relative abilities of candidate resistance modulators to reverse chloro-A Panamanian Aotus monkey-P. falciparum quine resistance in Aotus. Two phenothiazines, model has been used to determine if the reversal chlorpromazine and prochlorperazine, were the of chloroquine resistance could be confirmed in most effective at reversing resistance in the .4otus-vivo with a series of resistance modulators. A P.falciparum model. Combinations of these two previous study demonstrated that the combiphenothiazines plus chloroquine resulted in the nation ofdesipramine (50 mg/kg on day one and only cures obtained. An analog of chlorproma-25 mg/kg on days two and three) plus chlorozine (SKF 21133-A) that revwrses chloroquine quine (20 mg/kg for three days) could clear inresistance in vitro was not effective in this model. fection with the Vietnam Smith/RE strain; how-The optimal response with ketotifen and a tiaever, in each case parasitemia recrudesced by day pamil analog (Ro 11-2933) in combination with fourteen post-treatment. 10 In this study, the com-chloroquine was the suppression of parasitemia bination of chloroquine plus chlorpromazine or in Aotus monkeys. Verapamil and cyproheptaprochlorperazine confirmed reversal of chloro-dine, both potent reversing agents in vitro.
2 1 quine resistance in Aotus. This effect was dem-were not effective in reversing chloroquine reonstrated by clearance ofparasitemia and by cures sistance and probable drug toxicity was obobtained in six Aotus monkeys infected with the served. Tt is not known why verapamil and cychloroquine-resistant Vietnam Smith/RE strain.
proheptadine did not reverse chloroquine Clearance of parasitemia, followed by recrudesresistance in Aotus monkeys, but it could be due The results obtained in this study with antihwould be to identify potent resistance modula-istaminics and verapamil contrast with the retors that lack pronounced activities as antipsy-versal of chloroquine resistance demonstrated in chotics or antidepressants.
two mouse malaria models. ." . In the chioro-
